International      

India approves emergency use of remdesivir to treat COVID-19 patients

02 Jun 2020 18:11, Somoy English Desk
India approves emergency use of remdesivir to treat COVID-19 patients
India approves emergency use of remdesivir to treat COVID-19 patients

India's government said it has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients.

Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials and is at the forefront of the battle against COVID-19, which has no approved treatment or vaccine.

"(Remdesivir) approved on June 1 under emergency use with condition for five dose administration," the Drugs Controller General of India said in an email statement.

The drugmaker did not immediately respond to an email seeking further details.

As of Tuesday, India has 199,785 cases of coronavirus and has recorded 5,612 deaths, health ministry data showed.

Share:      

All News of International

View more

Popular News

Watch Live TV

Somoy TV Live SOMOY YOUTUBE SOMOY YOUTUBE
DOWNLOAD MOBILE APP